InvestorsHub Logo

jakedogman1

12/17/12 9:41 PM

#104854 RE: investingdog #104853

when looking at value, one looks at science and mgmt. ws has the value right when looking at mgmt. i would say it is overvalued when you look at what cj, dp and es bring to the party. any real horse power operates as a consultant.

EYEBUYSTOX

12/17/12 10:17 PM

#104857 RE: investingdog #104853

It won't take long for the investment community to catch up if the results are good. Like when we were at .39 and people asked why we weren't at $5? Then we were at $5 4 months later and people asked why we weren't at $20. It's all relative.

geocappy1

12/18/12 12:24 AM

#104864 RE: investingdog #104853

The pps was at $.40 several months back and the folks on this board realized based on data being given in Cc that the control group in the 2nd lung trial had an MOS of less than 6 months and the MOS for the treatment group was approaching 12 months by reading between the lines and continued buying. It turned out to be true and pps went to $5.40 before the third party error was discovered and the pps fell to $.70. It is now back to $1.28 and some hear believe they are going to salvage the 2nd line data. Those same people believe we may see a doubling of MOS in 1st line lung and pancreatic. The market didn't know before and they just may not know what is going on now. It wouldn't be the 1st time for a small biotech.
Of of risk and maybe a lot of reward. If you want low risk then buy bonds.

corporalagarn

12/18/12 6:35 AM

#104872 RE: investingdog #104853

Look up the word "delusional". That may help.